Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic

  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Gsk Plc ADR (NY: GSK )

33.96 +0.26 (+0.77%)
Official Closing Price Updated: 7:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Gsk Plc ADR

< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
35 36 Next >
Give peace a chance
Israeli fabless semiconductor maker Tower was bought by Intel for $5.4 bn today. 
Via Talk Markets
The Best Russell 2000 Stocks to Buy Before they Rebound
Some of the best stocks in the market are among the best Russell 2000 stocks to buy. Here's a list of a few of those choices. 
Via InvestorPlace
World Markets News For Monday
European markets were down over fear of Ukrainian battles. 
Via Talk Markets
Large Cap Biopharma- Well Positioned For Choppy Markets
If the past week is any indicator large-cap biopharma stocks are a good place to hide from the turbulence of 2022 markets. 
Via Talk Markets
Earnings Scheduled For February 9, 2022
Companies Reporting Before The Bell • Equinor (NYSE:EQNR) is projected to report quarterly earnings at $0.63 per share on revenue of $25.05 billion. 
Via Benzinga
A Look Into GlaxoSmithKline's Price Over Earnings
  
Via Benzinga
Stock Market Rally Stalls As Inflation, Treasury Yields Soar: Weekly Review
The stock market rally remains stuck in a recent range as the major indexes slashed weekly gains on hot inflation. Treasury yields surged. 
Via Investor's Business Daily
Preprint Suggests, Vir-GSK's COVID-19 Antibody Can Evade Omicron Sub-Variant
In January, amid the omicron surge, WHO's expert panel recommended GlaxoSmithKline Plc (NYSE 
Via Benzinga
Why Are Seagen Shares Sinking Today?
Seagen Inc (NASDAQ: SGEN) reported Q4 revenues 
Via Benzinga
Dampening Exuberance
The bond sell-off halted today but the Fed's plans mean this will resume. 
Via Talk Markets
GlaxoSmithKline: Q4 Earnings Insights
  GlaxoSmithKline (NYSE:GSK) reported its Q4 earnings results on Wednesday, February 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Glaxo's Q4 Pharma Sales Jump 20% Boosted By COVID-19 Treatment; Prepares For Spin-Off
GlaxoSmithKline Plc's (NYSE: GSK) turnover was  
Via Benzinga
Immunome Shares Seesaw After COVID-19 Antibody Cocktail Works Against Live Omicron Virus
Immunome Inc (NASDAQ: IMNM) shares rose before falling after reporting results from testing its experimental three-antibody cocktail  
Via Benzinga
Key Events This Week: All Eyes On The CPI
After what DB's Jim Reid describes as 
Via Talk Markets
A News Blizzard
Markets are still down despite very encouraging news in January when 467,00 new hires got jobs. 
Via Talk Markets
Sanofi Records Q4 Topline, Bottomline Growth As Blockbuster Eczema Drug Soars
Sanofi SA's (NASDAQ: SNY)  
Via Benzinga
GSK To Get $1.25B As Settlement For HIV Treatment Drug Patent Row With Gilead
GlaxoSmithKline plc (NYSE: GSK) has settled a patent dispute between ViiV Healthcare and Gilead Sciences Inc (NASDAQ: GILD). 
Via Benzinga
World Markets News for Tuesday
Exxon is splitting into 3 with its new restructuring move: upstream; chemicals; and low-carbon. 
Via Talk Markets
FDA Approves First Injectable For HIV Pre-Exposure Prevention - GSK, Pfizer Backed Treatment
The FDA has approved ViiV Healthcare's Apretude (cabotegravir extended-release injectable suspension 
Via Benzinga
Panic reversal
Crude oil inventories turned out to be fuller than expected, helping reduce the oil price rise. 
Via Talk Markets
10 Stocks to Buy That Could Make You a Millionaire in 2022
After this past year, it's going to be hard to find stocks to buy to make you a millionaire in 2022. Here are 10 that might do the trick. 
Via InvestorPlace
Markets Fears
Today markets dropped precipitously over fear of a Ukrainian invasion and higher interest rates and inflation. 
Via Talk Markets
FDA Clears Lyell Immunopharma' LYL132 Trial For Solid Tumors
The FDA has cleared Lyell Immunopharma Inc's (NASDAQ: LYEL) Investigational New Drug (IND) application to initiate a Phase 1 trial for LYL132 in solid tumors.... 
Via Benzinga
Activist Investor Nelson Peltz's Fund Buys Stake In Unilever: FT
Trian Fund Management LP, the activist hedge fund run by Nelson Peltz, has built a stake in Unilever PLC (NYSE: UL), the Financial Times reports, citing people with direct... 
Via Benzinga
Routine Vaccination Rates in Teens and Adults Continue to Lag Behind Pre-Pandemic Levels, Follow-up Analysis Shows
From GSK
Via Business Wire
Why Jim Cramer Like NextEra Energy And Lincoln Electric?
On CNBC’s "Mad Money Lightning Round," Jim Cramer said NextEra Energy, Inc. (NYSE: 
Via Benzinga
World Markets News
Today oil and gas inventories were seen as higher than expected while potential prices fell, both bullish. 
Via Talk Markets
Wednesday File
It sound odd but the real threat to markets is slowing Chinese growth which fell to 4% in Q4 from double that earlier last year. 
Via Talk Markets
Chopped Stocks
The day's theme is sell tech and buy banks. 
Via Talk Markets
23andMe Pivoting To Clinical Research: Could That Lead To A Turnaround For The Stock?
Genetic testing company 23andMe Holding Co. (NASDAQ: ME) took the unconventional route of a SPAC deal to go public, and the stock hasn't gained much traction since it began... 
Via Benzinga
< Previous 1 2
...
22 23 24 25 26 27 28 29 30
...
35 36 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.